JPMorgan moved off the sidelines on Teva Pharmaceuticals , citing its cost-cutting efforts. Analyst Chris Schott upgraded U.S.-listed shares of the Israeli pharmaceutical company…
Tech billionaire Elon Musk’s regulatory problems have started to fade…
The Kannai and Chukagai district at night, the hub of…